Grants and Contracts per year
Organization profile
About Us
For more than 40 years, the Markey Cancer Center has served the Commonwealth of Kentucky and is an integral part of the University of Kentucky and UK HealthCare. Markey is the only NCI-designated cancer center in Kentucky, and one of only a handful in the country. In addition, Markey Cancer Center has been listed in U.S. News and World Reports Top 50 Cancer Centers for the past three years.
The Markey Cancer Center was first designated by the National Cancer Institute in 2013 – a distinction that recognizes its extraordinary ability to conduct world-class research, launch ground-breaking clinical trials, and provide exceptional patient care. NCI-designated centers are a major source of discovery and development in the fight against cancer.
Membership in the Markey Cancer Center research community consists of investigators from across the university who have demonstrated scientific excellence and their commitment to collaborative work in cancer research. Each investigator works within one of three thematic research programs:
- Cancer Prevention and Control (CP)
- Molecular and Cellular Oncology (MCO)
- Translational Oncology (TO).
Additionally, Markey has established five shared resource facilities: Biospecimen Procurement and Translational Pathology (BPTP), Redox Metabolism (RM), Biostatistics and Bioinformatics (BB), Cancer Research Informatics (CRI), and Flow Cytometry and Immune Monitoring (FCIM); with two additional facilities under development: Patient-oriented and Population Sciences (POP) and Oncogenomics (OG), to aid researchers in their work.
For more information and resources, visit the Markey Cancer Center website.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Markey Cancer Center / Cancer Research Priority Initiative is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Research units
-
Cancer Prevention and Control Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Organizational unit: Department
-
Molecular and Cellular Oncology Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Organizational unit: Department
-
Translational Oncology Research Program
Markey Cancer Center / Cancer Research Priority Initiative
Organizational unit: Department
Profiles
-
Reuben Adatorwovor, Ph.D.
- Biostatistics - Assistant Professor
- Cancer Prevention and Control Research Program - Member
- Markey Cancer Center / Cancer Research Priority Initiative - Associate
Person
-
Adebola Adegboyega, Ph.D.
- College of Nursing - Assistant Professor
- Cancer Prevention and Control Research Program - Member
- Markey Cancer Center / Cancer Research Priority Initiative - Associate
- UNITE Research Priority Area
Person
-
Kenneth Ain, MD
- Internal Medicine - Professor
- Markey Cancer Center / Cancer Research Priority Initiative - Associate
- Translational Oncology Research Program - Member
Person
-
Center for Appalachian Research in Environmental Sciences: Administrative Core
Hahn, E., Arnett, D., Bauer, J., Cassis, L., Christian, J., Cox, N., Curry, T., DiPaola, R., Dignan, M., Evers, B. M., Fan, W., Haynes, E., Hoover, A., Kern, P., May, B., Miller, J., Pearson, K., Pennell, K., Richardson, K., Sanderson, W., Schoenberg, N., Stanifer, S., Stanley, S., Stratton, T., Stromberg, A., Swanson, H., Talbert, J., Unrine, J. & Heath, E.
National Institute of Environmental Health Sciences
6/3/23 → 4/30/28
Project: Research project
-
22-HN-37-MSD (689-07): A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell
Merck Sharp & Dohme Corporation
5/11/23 → 5/10/25
Project: Research project
-
Surveillance, Epidemiology, and End Results (SEER) Program
Durbin, E., Huang, B., Shelton, B., Tucker, T. & Ross, F.
5/1/23 → 4/30/24
Project: Research project
Research output
-
ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization
Lyon, A., Tripathi, R., Meeks, C., He, D., Wu, Y., Liu, J., Wang, C., Chen, J., Zhu, H., Mukherjee, S., Ganguly, S. & Plattner, R., Feb 2023, In: Cancers. 15, 3, 954.Research output: Contribution to journal › Article › peer-review
Open Access -
Accuracy of mandibular repositioning surgery using new technology: Computer-aided design and manufacturing customized surgical cutting guides and fixation plates
Yoo, H. J., Hartsfield, J. K., Mian, A. S., Allan, B. P., Naoum, S., Lee, R. J. H. & Goonewardene, M. S., Mar 2023, In: American Journal of Orthodontics and Dentofacial Orthopedics. 163, 3, p. 357-367.e3Research output: Contribution to journal › Article › peer-review
-
A Colorimetric Assay to Identify and Characterize Bacterial Primase Inhibitors
Pang, A. H. & Tsodikov, O. V., 2023, Methods in Molecular Biology. p. 283-301 19 p. (Methods in Molecular Biology; vol. 2601).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
Prizes
-
-
-
Travel Award, Summer Training Course in Experimental Aging Research
Messaoudi Powers, Ilhem (Recipient), 2003
Prize: Honorary award
-
Motivational Interviewing to Influence Patient Decision Making
Stacy Stanifer (Speaker)
Oct 1 2019Activity: Talk or presentation › Oral presentation
-
The RADAR Project. A community-engaged, citizen-science approach to reduce radon exposure in the home and improve environmental health literacy in rural Kentucky
Stacy Stanifer (Speaker)
Sep 1 2021Activity: Talk or presentation › Oral presentation
-
Radon Update: BREATHE
Stacy Stanifer (Speaker) & K Simpson (Speaker)
Nov 1 2021Activity: Talk or presentation › Invited talk